Lannett Co., Inc.
(NYSE : LCI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
3.06%134.970.7%$1067.69m
BMYBristol-Myers Squibb Co.
0.14%58.591.4%$771.91m
MRKMerck & Co., Inc.
0.41%84.900.7%$753.42m
PFEPfizer Inc.
2.00%37.280.9%$727.22m
ABBVAbbVie, Inc.
1.13%88.622.3%$702.13m
LLYEli Lilly & Co.
1.61%113.181.1%$394.19m
NVSNovartis AG
0.59%90.040.2%$152.06m
AZNAstraZeneca Plc
0.17%47.451.2%$148.90m
RETAReata Pharmaceuticals, Inc.
-2.23%198.913.7%$144.23m
GSKGlaxoSmithKline Plc
0.57%44.100.2%$119.80m
NVONovo Nordisk A/S
-1.05%57.280.1%$78.72m
SNYSanofi
2.42%46.110.2%$64.54m
RARXRa Pharmaceuticals, Inc.
0.32%46.750.8%$39.41m
CNSTConstellation Pharmaceuticals, Inc.
1.48%38.480.0%$30.75m
BHVNBiohaven Pharmaceutical Holding Co. Ltd.
4.20%51.080.0%$25.10m

Company Profile

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Philadelphia, PA.